...
首页> 外文期刊>American Journal of Translational Research >MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1
【24h】

MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1

机译:MiR-4644在膀胱癌患者的血浆外泌体中上调,并通过靶向UBIAD1来促进膀胱癌进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Exosome-encapsulated microRNAs (miRNAs) have been identified as potential cancer biomarkers and pro-tumorigenic mediators for several cancers. However, the miRNA profiling in BCa-Exo (exosomes from plasma of patients with bladder cancer) has not yet been explored. Hence, the aim of this study was to analyze the miRNA profiling in BCa-Exo and to explore the function and mechanism of the selected miR-4644 in BCa progression. Of the 8 differentially expressed miRNAs in BCa-Exo relative to NC-Exo (exosomes from plasma of normal control subjects), hsa-miR-4644 was the only upregulated (fold change 2.0, P 0.05) miRNA, which was further confirmed to be upregulated in plasma of BCa patients and BCa cell lines. Further in vitro assays demonstrated that miR-4644 mimic promoted, whereas miR-4644 inhibitor suppressed BCa cell proliferation and invasion. miR-4644 negatively regulated expression of UBIAD1 (UbiA prenyltransferase domain-containing protein 1) by directly binding to its 3’-UTR region. UBIAD1 overexpression effectively abrogated the promoting effects of miR-4644 mimic on BCa proliferation, migration, and invasion. Additionally, intratumoral injection of miR-4644 antagomir downregulated miR-4644 expression in tumors and suppressed tumorigenesis in mouse xenografts. Collectively, miR-4644 promotes BCa progression by targeting UBIAD1. miR-4644 may be an important therapeutic target for BCa treatment.
机译:外部封装的MicroRNA(miRNA)已被鉴定为几种癌症的潜在癌症生物标志物和促致瘤介质。然而,BCA-EXO(来自膀胱癌患者的血浆的外来体)的miRNA分析尚未探讨。因此,本研究的目的是分析BCA-EXO中的miRNA分析,并探讨BCA进展中所选miR-4644的功能和机制。在相对于NC-EXO中的8个差异表达的miRNA(来自正常对照对象的血浆的外来),HSA-miR-4644是唯一的上调(折叠变化& 2.0,p& 0.05)miRNA,即进一步证实在BCA患者和BCA细胞系的血浆中升级。进一步的体外测定证明MIR-4644促进促进,而MiR-4644抑制剂抑制BCA细胞增殖和侵袭。 MiR-4644通过直接结合其3'-UTR区域对UbiAd1(Ubia戊酰基转移酶结构域域1)的表达进行负调节。 UBIAD1过表达有效地废除了MIR-4644模拟BCA增殖,迁移和侵袭的促进效果。另外,妥善注射miR-4644 intagomir下调MiR-4644在肿瘤中的表达,并在小鼠异种移植物中抑制肿瘤内酯。统称,MIR-4644通过针对UBIAD1促进BCA进展。 miR-4644可以是BCA治疗的重要治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号